Reimbursement for medicine

Read about how much you can get in reimbursement for your medicine, which types of reimbursement you can get in Denmark, and what the rules are for the different types of reimbursement.

Go to theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2


Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.


Danish Medicines Agency establishes that chronic urticaria could be a side effect of the Spikevax vaccine

05 April 2024

The European Pharmacovigilance Risk Assessment Committee (PRAC) has reassessed if chronic urticaria could be a side effect after vaccination with the Spikevax vaccine from Moderna. This follows a review from the Danish Medicines Agency, which has investigated data and reports from patients across the European countries.

Survey on strategy for Ph. Eur. quality standards for monoclonal antibodies

11 March 2024

Regulatory training on transitional trials in CTIS with open question and answers session

13 February 2024

Continued control of companies' uploading of leaflets to the Danish Medicines Agency's portal DKMAnet

01 February 2024